| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02113499 |
| P698 | PubMed publication ID | 9039530 |
| P50 | author | Jacques F. Meis | Q51269909 |
| P2093 | author name string | A Voss | |
| J L le Noble | |||
| F M Verduyn Lunel | |||
| N A Foudraine | |||
| P2860 | cites work | Epidemiology of nosocomial infections in adult intensive care units. | Q51195335 |
| Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. | Q54198739 | ||
| Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System | Q64128267 | ||
| Comparative Efficacy of Alternative Hand-Washing Agents in Reducing Nosocomial Infections in Intensive Care Units | Q67469880 | ||
| Risk factors for nosocomial candidemia: a case-control study in adults without leukemia | Q69391246 | ||
| Risk factors for hospital-acquired candidemia. A matched case-control study | Q69771679 | ||
| Excess mortality in critically ill patients with nosocomial bloodstream infections | Q70212614 | ||
| Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit | Q70229614 | ||
| Candida glabrata, Candida krusei, non-albicans Candida spp., and other fungal organisms in a sixty-bed national cancer center in 1989-1993: no association with the use of fluconazole | Q72588936 | ||
| Candida colonization and subsequent infections in critically ill surgical patients | Q24535524 | ||
| A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study | Q29615430 | ||
| Outbreak of systemic Candida albicans in intensive care unit caused by cross infection | Q34491377 | ||
| Nosocomial infections: validation of surveillance and computer modeling to identify patients at risk | Q37908596 | ||
| Candida: an increasingly important pathogen in the nursery. | Q39643323 | ||
| Importance of Candida species other than C. albicans as pathogens in oncology patients | Q40512068 | ||
| Nosocomial infections in intensive care units: an overview of their epidemiology, outcome, and prevention | Q40630104 | ||
| Long-term survival after intensive care unit admission with sepsis | Q44595801 | ||
| Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients | Q44881498 | ||
| P433 | issue | 1 | |
| P921 | main subject | intensive care unit | Q5094647 |
| candidemia | Q54946225 | ||
| P304 | page(s) | 8-11 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Infection | Q15710156 |
| P1476 | title | Candidemia in intensive care unit patients: risk factors for mortality | |
| P478 | volume | 25 |
| Q33404911 | A Candida albicans early stage biofilm detachment event in rich medium |
| Q46272854 | Anticandidal activity of hetero-dinuclear copper(II) Mn(II) Schiff base and its potential action of the mechanism. |
| Q36633724 | Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis |
| Q36641985 | Bench-to-bedside review: Candida infections in the intensive care unit |
| Q21194915 | Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit |
| Q36670916 | Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies. |
| Q43704648 | Candidaemia in cancer patients and in children in a neonatal intensive care unit |
| Q51814641 | Candidemia in a Brazilian hospital: the importance of Candida parapsilosis. |
| Q47619707 | Candidemia in critically ill patients: difference of outcome between medical and surgical patients |
| Q24195090 | Central venous catheter (CVC) removal for adult patients with candidaemia |
| Q26471135 | Central venous catheter (CVC) removal for patients of all ages with candidaemia |
| Q31054881 | Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study |
| Q56019292 | Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3 |
| Q33943521 | Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. |
| Q40492126 | Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia |
| Q33548720 | Dispersion as an important step in the Candida albicans biofilm developmental cycle |
| Q36607424 | Endogenous Candida endophthalmitis |
| Q34273626 | Epidemiology of Candida species infections in critically ill non-immunosuppressed patients |
| Q37624691 | Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients |
| Q47094301 | Evaluation of Candida Scoring Systems to Predict Early Candidemia: A Prospective and Observational Study at a Tertiary Care Hospital, Uttarakhand |
| Q35504886 | Experience with invasive Candida infections |
| Q41750558 | Fungal infection in the intensive care unit |
| Q35072860 | Genetic relationships between Candida albicans strains isolated from dental plaque, trachea, and bronchoalveolar lavage fluid from mechanically ventilated intensive care unit patients |
| Q34721320 | Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis |
| Q36128249 | Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials |
| Q40513183 | Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland |
| Q44590119 | Invasive candidiasis in non-neutropenic adults : Guideline-based management in the intensive care unit |
| Q37514625 | Invasive candidiasis: an overview from Taiwan |
| Q46711915 | Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists |
| Q37643057 | Invasive fungal infections in the ICU. |
| Q73615024 | Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group |
| Q51193209 | Low incidence of candidaemia among neutropenic patients treated for haematological diseases. |
| Q35904821 | Management of invasive candidiasis in critically ill patients |
| Q73466515 | Non-albicans Candida species isolated from plastic devices |
| Q33634724 | Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review |
| Q33685839 | Nosocomial fungal infections: candidemia |
| Q33312275 | Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans |
| Q38009066 | Practical considerations on current guidelines for the management of non-neutropenic adult patients with candidaemia |
| Q39746568 | Rapid identification of Candida species by confocal Raman microspectroscopy |
| Q46838277 | Relation between stage of endogenous fungal endophthalmitis and prognosis |
| Q44217079 | Risk factors for candidaemia in critically ill patients: a prospective surveillance study |
| Q80374897 | Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis |
| Q35119972 | Septic shock due to candidemia: outcomes and predictors of shock development |
| Q43578717 | Systemic Candida infection in University hospital 1997-1999: the distribution of Candida biotypes and antifungal susceptibility patterns |
| Q48555324 | The Lowbury Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability |
| Q35959489 | Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature |
| Q37443139 | Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B. |
| Q33840086 | Treatment of fungal infections in surgical patients using conventional antifungals |
| Q44621426 | Voriconazole salvage treatment of invasive candidiasis. |
| Q73972314 | [Epidemiology and prognostic factors of systemic candidiasis in intensive care units] |
| Q28534551 | continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis |
Search more.